Concourse Financial Group Securities, Inc. Glaukos Corp Transaction History
Concourse Financial Group Securities, Inc.
- $1.67 Billion
- Q4 2024
A detailed history of Concourse Financial Group Securities, Inc. transactions in Glaukos Corp stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 76 shares of GKOS stock, worth $9,121. This represents 0.0% of its overall portfolio holdings.
Number of Shares
76
Previous 76
-0.0%
Holding current value
$9,121
Previous $9,000
22.22%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding GKOS
# of Institutions
355Shares Held
50.1MCall Options Held
282KPut Options Held
401K-
Black Rock Inc. New York, NY8.04MShares$965 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.97MShares$717 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA2.16MShares$259 Million0.06% of portfolio
-
State Street Corp Boston, MA2.06MShares$248 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.93MShares$232 Million0.08% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $5.71B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...